BioTech Review

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based Cellgorithm technology, which lays the groundwork for programmable control of gene activity in human stem cells and offers an alternative to the slow, variable manual processes researchers use today.

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly popular in U.S. grocery stores. But the plants that produce these bright yellow-orange fruits grow wild and unruly—reaching heights that make large-scale farming impractical.

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label expansion and stronger commercial uptake.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in Science Advances detailing the company's CRISPR-based Cellgorithm technology, which lays the groundwork for programmable control of gene activity in human stem cells and offers an alternative to the slow, variable manual processes researchers use today.

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. AI chatbots can sway voters better than political advertisements The news: Chatting with a politically biased AI model is more effective than political ads at nudging both Democrats and Republicans to support presidential candidates…

Protein composition of muscular extracellular matrix impacts the function of muscular stem cells in repair and regeneration of muscles during aging. The role of tenascin-C has been clarified in a new study in mice. The post Muscle Stem Cells Bolstered by ECM Protein Tenascin-C appeared first on GEN - Genetic Engineering and Biotechnology News.

For the scientific enterprise, 2025 was marked by setbacks and challenges. But scientists are no strangers to adversity—the ability to overcome obstacles is built into our training. In turn, research labs across […] The post GEN Editors Reflect on Six of the Biggest Stories of the Year appeared first on GEN - Genetic Engineering and Biotechnology News.

Your skin is in a constant state of reinvention. Every month, your body sheds and regenerates its entire outer layer—a complete turnover powered by tiny, tireless stem cells. These same cells spring into action when you get a cut, healing wounds with remarkable speed.

The new gene therapy focuses on a type of DNA error shared by a wide range of rare inherited conditions. The post One Dose of This Gene Editor Could Defeat a Host of Genetic Diseases Suffered by Millions appeared first on SingularityHub.

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two communities: "There was a clear gap in communication."

Scientists in Melbourne have discovered how tiny electrical pulses can steer stem cells as they grow, opening the door to new improved ways of creating new tissues, organs, nerves and bones.

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their sights—trying to capture the interplay between certain genes and the pediatric developmental disorders they cause.

Scientists in Melbourne have discovered how tiny electrical pulses can steer stem cells as they grow, opening the door to new improved ways of creating new tissues, organs, nerves and bones.

Stem cells exist in order to minimize the number of cells capable of unrestricted replication; most cells in the body are limited in the number of times that they can divide. This limit serves to reduce the risk of cancer - and other severe disruptions that could result from unlimited replication of a malfunctioning cell - to an acceptably low level to enable evolutionary success. Stem cells provide a supply of daughter somatic cells to replace those that are lost over time, due to limited somatic cell replication. In actuality, stem cells spend much of their time in a state of quiescence, without replicating. This is necessary to preserve their function and minimize damage over the course of a lifetime. When forced into excessive activity, […]

Ben Jiang / South China Morning Post: Chinese short-video company Kuaishou launches Kling Video O1, saying it is the first multimodal AI model to unify video generation, editing, and post-production  —  Kuaishou expects the new model's abilities to drive its adoption by filmmakers, production studios, advertisers and influencers

Age-related loss of function in hematopoietic stem cells resident in the bone marrow is an important component of immune system aging, and thus important to aging as a whole. There is a tendency to think of cells only in terms of chemistry, but some of that chemistry is linked to structure, mechanical forces, and the physical properties of surrounding tissues. Researchers here find that RhoA, a key protein in a cell's response to mechanical stimulus, is important in loss of function in aged hematopoietic stem cells. It is something of an open question as to how much of this importance is driven by changes in the mechanical properties of surrounding tissues versus epigenetic changes inside the cell that affect its structure, but RhoA inhibition clearly […]

A new study, led by the University of Vienna and the Alfred Wegener Institute in Bremerhaven, shows how the eyes of adult marine bristleworms continue to grow throughout life – driven by a ring of neural stem cells reminiscent of vertebrate eyes.

A new study, led by the University of Vienna and the Alfred Wegener Institute in Bremerhaven, shows how the eyes of adult marine bristleworms continue to grow throughout life—driven by a ring of neural stem cells reminiscent of vertebrate eyes. What's more, these stem cells respond to environmental light.

In a groundbreaking advancement that challenges longstanding paradigms in HIV research, scientists have reported an extraordinary case of durable HIV remission achieved without the classic CCR5 Δ32 homozygous mutation previously deemed critical for curing the virus. The study, recently published in Nature by Gaebler, Kor, Allers, and colleagues, unveils the compelling story of a male […]

The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a potential one-and-done treatment for alpha-1 antitrypsin deficiency.

Fat tissue stem cells have shown a remarkable ability to heal spinal fractures and restore bone strength in rats. The discovery could pave the way for safer, less invasive treatments for osteoporosis and other bone diseases. Fat-Derived Stem Cells Tested for Spinal Fracture Repair A research group at Osaka Metropolitan University has explored the use [...]

CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio. CRISPR made up roughly 3.8% of ARK Investment’s disclosed equity portfolio at third-quarter-end, with a position valued at approximately $634 million. ARK decreased its exposure slightly in Q3, reducing its holdings from 10.18 million to 9.79 million shares. As […]

International researchers have figured out a simple way to make mini lab-grown lungs, which can be used to test lung disease treatments in the labs. These “organoids”, which are clusters of cells that contain the same cell types as full-sized organs, are useful in medical research but usually difficult to make. Using an oxygen-infused growth tank which is continuously stirred, the team was able to produce lots of lung organoids at once, and say the process could be automated. While more tests need to be done to see how well they mimic real-life conditions in the body, the team says that if made from a patient’s own cells, they could potentially test treatments, such as cancer treatments, before someone tries them for real.

BioQuest Hackathon 2025 | GBU BioQuest Hackathon 2025 | BioQuest Hackathon Registrations BioQuest Hackathon 2025 is gearing up to be one of the most anticipated biotech-AI innovation challenges of the year, and GBU BioQuest Hackathon 2025 is now inviting brilliant minds to register, compete, and innovate. With BioQuest Hackathon Registrations officially open, participants across biotechnology, […] The post BioQuest Hackathon 2025 Registrations Open – Jointly Organised by Snehshilp Foundation, Gujarat Biotechnology University and Satani Research Centre appeared first on BioTecNika.

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its Market Outperform rating and $86 price target for CRISPR Therapeutics AG (NASDAQ:CRSP) on November 11. The firm discussed positive findings from CRISPR’s American Heart Association presentation on CTX310, targeted at ANGPTL3 for a variety of cholesterol issues. […]

In recent years, advances in molecular biology have transformed our approach to diagnosing viral infections, particularly in immunocompromised patients such as those undergoing kidney transplantation. A team of researchers led by Liu, Y., Xu, JS., and Cao, L. has developed a groundbreaking CRISPR-based assay specifically targeting BK virus and JC virus infections in this vulnerable […]

Discover what makes North Carolina’s Research Triangle Park’s life sciences and biotech ecosystem so successful. The post Research Triangle Park: A closer look at North Carolina’s burgeoning biotech hub appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

In a groundbreaking study that ushers in a new era of immunotherapy, researchers have adeptly harnessed the capabilities of mesenchymal stem cells (MSCs) through innovative mRNA engineering. This endeavor has led to the inception of a promising allogeneic cell therapy termed DC-25, showcasing its potential to transcend the limitations associated with conventional autologous therapies. Autologous […]

$3M Pre-Series A Boost for CRISPR Innovator CrisprBits – A Biotech Startup Indian biotech startup CrisprBits has just raised US$3 million in a Pre-Series A funding round. This milestone move could shape the future of CRISPR-powered diagnostics, gene editing, and sustainable biotechnology. The round was led by Spectrum Impact, the family office of Rajendra Gogri […] The post Biotech Startup CrisprBits Bags $3M to Expand CRISPR Diagnostics and R&D appeared first on BioTecNika.

A range of CRISPR gene therapies are taking aim at chronically high cholesterol, reducing the risk of heart disease. The post CRISPR Slashes ‘Bad Cholesterol’ Levels by 95 Percent in Early Results appeared first on SingularityHub.

In recent years, the field of cancer immunotherapy has gained immense traction, representing a groundbreaking shift in how we approach the treatment of malignancies. Researchers are increasingly turning to dendritic cells as a pivotal component in harnessing the power of the immune system to combat cancer. A recent study published by Prakash, Cortez, and Jayaraman […]

In recent advancements in the realm of genetic engineering, a pivotal study has emerged that focuses on the development of knockout cardiac muscle cell lines utilizing integrase-deficient lentivirus-mediated CRISPR/Cas9 gene editing. This innovative approach is significant for researchers aiming to uncover the intricacies of cardiac muscle function and pathology. By employing a robust genetic modification […]

Texas A&M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower particles. These energized stem cells then transfer their surplus “power packs” to weakened cells, reviving their energy production and resilience. The method bypasses many limitations of current mitochondrial therapies and could offer long-lasting effects. It may open the door to treatments for aging tissues and multiple degenerative diseases.

The allegation comes from a lawsuit filed against Campbell's last week by Robert Garza. The security analyst joined Campbell's New Jersey headquarters remotely in September 2024.Read Entire Article

In a groundbreaking study that promises to revolutionize our understanding of traumatic brain injury (TBI) and its systemic effects, researchers have delved into the intricate connections between neurological trauma and digestive health. This research, led by Eslami et al., reveals a significant interplay between inflammatory responses in the digestive system and oxidative stress levels following […]

Scientists have discovered a method of helping human stem cells thrive in an animal embryo—a key development in efforts to grow human organs in animals for medical transplants.

Researchers use nanoflower-enhanced stem cells to supply extra mitochondria to damaged cells, restoring energy production and cell function without genetic modification.

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the most oversold biotech stocks to invest in. Following the company’s third-quarter financial results, Oppenheimer reaffirmed its Outperform rating and $95 price target for CRISPR Therapeutics AG (NASDAQ:CRSP) on November 11. CRISPR Therapeutics AG (NASDAQ:CRSP) reported a lower-than-anticipated loss of $1.17 per share against the expected $1.26 per share, […]

Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the most oversold biotech stocks to invest in. On November 11, Jones Trading dropped Intellia Therapeutics, Inc. (NASDAQ:NTLA) from Buy to Hold. The downgrade came after Intellia announced on November 6, along with its third-quarter 2025 earnings, that a next-z treated patient who had originally met Hy’s Law criteria […]

CRISPR Lets Scientists Create the World’s First Spider That Spins Glowing Red Silk What if one of nature’s toughest fibers could be redesigned—directly from the creature that spins it? For years, researchers dreamed of editing spiders the same way they edit flies, fish, or crops. But spiders, with their sensitive biology and solitary personalities, refused […] The post CRISPR Breakthrough: Scientists Engineer Spider That Spins Glowing Red Silk appeared first on BioTecNika.

India’s Homegrown Gene-Editing Breakthrough Could Transform How Genetically Modified Crops Are Made Imagine a time in the future when Indian researchers will be able to refine crops with the same level of accuracy as the best biotech labs in the world, but at a much lower cost, without any restrictions on international licensing, and using […] The post India’s ICAR Unveils Desi Gene-Editing Tool for Genetically Modified Crops appeared first on BioTecNika.

A federal commission is calling for significant changes to the way the U.S. government funds and assesses scientific research.

Researchers at the Icahn School of Medicine at Mount Sinai have discovered how to reverse aging in blood-forming stem cells in mice by correcting defects in the stem cell's lysosomes.

Researchers at the Icahn School of Medicine at Mount Sinai have discovered how to reverse aging in blood-forming stem cells in mice by correcting defects in the stem cell's lysosomes. The breakthrough, published in Cell Stem Cell, identifies lysosomal hyperactivation and dysfunction as key drivers of stem cell aging and shows that restoring lysosomal slow degradation can revitalize aged stem cells and enhance their regenerative capacity.

In this video, Mark Sulkowski, MD, discusses clinical trials in gene editing therapy and basic studies in epigenetic silencing as presented at The Liver Meeting.Sulkowski noted that this type of testing shows these trials have moved beyond laboratory and animal models in hepatitis.“One of the major themes is that this has moved into human testing and it’s conceivable that at some point we’ll be able to leverage these types of approaches,” Sulkowski, director of the division of infectious diseases at Johns Hopkins Bayview Medical Center, told Healio.

UC Davis researchers engineered wheat that encourages soil bacteria to convert atmospheric nitrogen into plant-usable fertilizer. By boosting a natural compound in the plant, the wheat triggers bacteria to form biofilms that enable nitrogen fixation. This breakthrough could cut fertilizer use, reduce pollution, and increase yields. It also offers huge potential savings for farmers worldwide.

© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://about.seekingalpha.com/terms). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.

New research on APOE4 and CRISPR brings hope for slowing Alzheimer’s progression.

Aging is defined as the deterioration of function over time, and it is one of the main risk factors for numerous chronic diseases. Although aging is a complex phenomenon affecting the whole organism, it is proved that the solely manifestation of aging in the hematopoietic system affects the whole organism. Last September, Dr. M. Carolina Florian and her team revealed the significance of using blood stem cells to pharmacologically target aging of the whole body, thereby suggesting rejuvenating strategies that could extend healthspan and lifespan.

In associate professor Mauro Tambasco's lab, researchers at all levels work together to develop innovative approaches to fighting cancer.

In a groundbreaking study conducted by Zhang et al., the intricate relationship between chemotherapy and cancer stem cell dynamics in lung cancer has been illuminated. This study reveals how cisplatin, a commonly used chemotherapeutic agent, activates the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, which in turn promotes the formation of lung cancer […]

In a groundbreaking advancement that promises to revolutionize on-site infectious disease diagnosis and pandemic surveillance, researchers have unveiled a thermally programmed one-pot CRISPR assay designed for rapid, sensitive, and highly specific viral detection. This novel technique, detailed in a recent publication in Nature Communications, integrates thermal programming protocols with CRISPR-based molecular recognition to deliver a […]

In research, induced pluripotent stem (iPS) cells are derived from skin, urine, or blood samples and developed into other cells, like heart tissue, that researchers want to study.

Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging non-repetitive loci, performing multi-locus visualization, or working with primary cells.

FRIDAY, Nov. 21, 2025 — A new gene-editing strategy may one day help many people with rare genetic diseases.In a new study published Wednesday in the journal Nature, researchers say this new approach could make future treatments easier and less c...

In a new study publishing November 19 in the Cell Press journal Trends in Biotechnology, researchers used a gene-editing technology called CRISPR to increase a fungus's production efficiency and cut its production-related environmental impact by as much as 61%-all without adding any foreign DNA.

Recent advancements in microbiological research have unveiled intricate mechanisms underlying the CRISPR-Cas systems, particularly focusing on the type III-B variant. Central to this evolution are the findings surrounding the interactions specifying the recognition of nonself target RNA and the subsequent synthesis of S-adenosyl methionine-adenosine monophosphate (SAM-AMP). This component is critical for initiating immune responses in […]

A biotech venture capitalist anticipates it’s just the start of a wave of M&A in the industry.

Gene Therapy for Sickle Cell Disease: India Launches First Indigenous CRISPR Breakthrough ‘BIRSA 101’ For the very first time in India, a Healthcare treatment stands not just as another disease management option, but as a possibility to stop a lifelong and painful condition at its root. Gene therapy for Sickle Cell Disease represents a breakthrough […] The post Gene Therapy for Sickle Cell Disease: India Launches First Indigenous CRISPR Breakthrough ‘BIRSA 101’ appeared first on BioTecNika.

Researchers at the Eye Genetics Research Unit at Children's Medical Research Institute (CMRI) are the first in the world to use stem cells to study one of the genetic causes of Leber Congenital Amaurosis (LCA)—a rare condition that causes severe vision loss in babies and young children. Their findings suggest that gene therapy could soon help prevent blindness in affected kids.

Whether neural organoids feel pain or should be placed in animals are among the questions swirling around biology’s hot new technology

Researchers at the Eye Genetics Research Unit at Children’s Medical Research Institute (CMRI) are the first in the world to use stem cells to study one of the genetic causes of Leber Congenital Amaurosis (LCA) — a rare condition that causes severe vision loss in babies and young children. Their findings suggest that gene therapy could soon help prevent blindness in affected kids.

Google is following Tuesday’s launch of Gemini 3 Pro with Nano Banana Pro. The image generation and editing model is officially Gemini 3 Pro Image, but the viral moniker is sticking around. more…

Researchers are investigating gene editing as a potential treatment for progeria, a rare genetic disorder that causes rapid aging in … Continue reading "Gene editing may be the potential cure for progeria, a condition causing rapid aging in children" The post Gene editing may be the potential cure for progeria, a condition causing rapid aging in children appeared first on Longevity.Technology - Latest News, Opinions, Analysis and Research.

Advances in 3D bioprinting technology could pave the way for new approaches to heart disease treatment and disease modeling. Researchers … Continue reading "Researchers achieve bioprinting milestone with functional human heart tissue" The post Researchers achieve bioprinting milestone with functional human heart tissue appeared first on Longevity.Technology - Latest News, Opinions, Analysis and Research.

CRISPR Cas9 Technology Revives the Lost Gene Researchers at Georgia State University have reactivated an extinct gene that humans lost millions of years ago using CRISPR Cas9 technology. This gene codes for an enzyme that breaks down Uric Acid, further lowering its accumulation in the body. The study reveals that this approach leads to new […] The post Researchers Restore Ancient Gene to Fight High Uric Acid and Fatty Liver using CRISPR Cas9 Technology appeared first on BioTecNika.

The landscape of genome editing has evolved significantly over the past decade, with CRISPR-Cas systems leading the charge as transformative tools for genetic manipulation. One of the most pressing challenges in adopting CRISPR technology is the identification and assessment of off-target effects that can lead to unintended genomic modifications. A novel technique, BreakTag, has been […]

The landscape of genome editing has evolved significantly over the past decade, with CRISPR-Cas systems leading the charge as transformative tools for genetic manipulation. One of the most pressing challenges in adopting CRISPR technology is the identification and assessment of off-target effects that can lead to unintended genomic modifications. A novel technique, BreakTag, has been […]

Researchers used CRISPR to enhance a naturally meat-like fungus, boosting its digestibility and production efficiency. The modified strain grows faster, uses far fewer resources, and lowers greenhouse gas emissions by up to 60%. It also dramatically outperforms chicken farming in land and water use. The findings highlight a promising path for eco-friendly protein. CRISPR Boosts [...]

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases.

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases.

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases.

Explore how gene editing medicine and personalized medicine future breakthroughs are revolutionizing health innovation gene therapy, offering precise, transformative treatments and medical breakthroughs for complex diseases.

Sara Fischer / Axios: Fox News hires Palantir to build tools that help journalists produce stories across Fox platforms and social media; Fox won't use AI to generate editorial copy  —  Fox News Media has been working with Palantir for the past year to build a suite of custom AI newsroom tools alongside its journalists …

Whether neural organoids feel pain or should be placed in animals are among the questions swirling around biology’s hot new technology

Scientists have genetically modified human mesenchymal progenitor cells to express a more potent version of the “longevity gene” FOXO3, producing rejuvenative effects in monkeys, mice, […]

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by genetic mutations. But so far, attempts to use the technology to address brain-based genetic disorders have proved challenging in the lab.

In a successful transplant in a man with brain death, scientists prevented the immune system from attacking a genetically modified pig kidney for 61 days, the longest such an experiment has lasted

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, Canaccord Genuity analyst John Newman reaffirmed a Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), setting a price target of $850. Earlier on November 8, Regeneron Pharmaceuticals, Inc. reported positive results from Phase 2 clinical trials […]

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, RBC Capital raised its price target for CRISPR Therapeutics AG (NASDAQ:CRSP) stock from $42 to $50. The firm kept the Sector Perform rating on the shares. The analysts noted that CASGEVY, CRISPR’s leading product, missed […]

In a groundbreaking leap forward for oncological research, scientists are now harnessing the power of 3D bioprinting to unravel the complex biology of breast cancer, heralding a new era in personalized medicine and therapeutic development. This innovative technology promises not only to revolutionize the way we model tumor progression but also to refine drug efficacy […]

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degeneration (AMD) stands as one of the primary causes of permanent vision loss among adults aged 60 and older. The disease affects the macula, the central region [...]

For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added biological coatings. The development opens the door to more controlled and humane neurological drug testing.

In this article, we will take a look at the 9 Best Gene-Editing Stocks to Buy According to Hedge Funds. Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism. This concept was merely a theory for many years until the 1970s, when scientists were […]

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in lung cancer.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in lung cancer. The approach restores drug sensitivity and slows tumor growth. The findings are published in the journal Molecular Therapy Oncology.

Study shows gene editing restores drug sensitivity by targeting NRF2, with potential across multiple tumor types.

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were edited, making it practical for real-world treatment. Since NRF2 fuels resistance in several cancers, the approach could have broad impact.

In a groundbreaking advancement poised to reshape the landscape of cancer treatment, researchers at ChristianaCare’s Gene Editing Institute have unveiled a novel approach to combat chemotherapy resistance in lung cancer through precise gene editing techniques. Central to this pioneering study is the targeting of the NRF2 gene, a critical regulator implicated in the cancer cells’ […]

In a groundbreaking advance for spinal cord injury treatment, researchers have achieved unprecedented restoration of forelimb function in primates through the transplantation of human embryonic stem cell-derived spinal cord neural stem cells (H9-scNSCs). This study, recently published in Nature Biotechnology, showcases a remarkable leap in cell therapy by not only advancing functional recovery but also […]

Venture capital funding for life sciences startups plummeted after legal changes weakened the patent system, according to new research that confirms the close relationship […] The post Ahead of BIO IP Conference, research highlights why biotech needs strong patents appeared first on Bio.News.

The new fund will mostly support biotechs making new drugs, with investments spanning from initial financings to follow-on rounds. 

In a groundbreaking study published in Gene Therapy, researchers have illuminated the possibilities of gene editing for collagen disorders, highlighting significant advancements and future perspectives in the field. Collagen, the most abundant protein in the human body, plays a critical role in maintaining the structural integrity of various tissues, including skin, bones, and connective tissues. […]

By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human liver models. The breakthrough hints at a future where gout and several metabolic diseases could be prevented at the genetic level.

In the evolving landscape of parasitic disease control, the latest developments in genetic manipulation of Leishmania parasites hold transformative potential. Recent advancements employing the revolutionary CRISPR/Cas9 genome editing system have opened new frontiers in understanding and combating leishmaniasis, a debilitating disease affecting millions worldwide. This breakthrough, meticulously detailed by Gundogdu and Islek, marks a pivotal […]

In the ever-evolving world of agricultural science, researchers are relentlessly searching for innovative methods to enhance crop resilience against the onslaught of environmental stressors. Recent breakthroughs in gene editing have opened new avenues for scientists aiming to bolster the defenses of crop varieties against factors such as drought, salinity, and pest infestations. Among these advancements, […]